Developer docs
API playgroundTry for free, no card

Search company profiles

Hercules Capital

Full company profile

uuid00006ru

Namestring
Hercules Capital
Legal namestring
Hercules Capital, Inc.
Websiteurl
htgc.com
Company typeenum
Public
Founded yearint
2003
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersSan Mateo, United States
HQ citystring
San Mateo
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture debt financing, senior secured loans, business development company, growth capital lending, non-dilutive financing
Industry3 codes
PRIMARYFSANAIAI
Venture Debt with Warrants (Hybrid Debt-Equity)
SECONDARYFSANAIAB
Independent Venture Debt Funds / Platforms
SECONDARYFSANAIAG
Venture Growth / Recurring Revenue Credit Funds
NAICS code2 codes
  • Funds, Trusts, and Other Financial Vehicles525
  • Commercial Banking522110
SIC code1 code
  • Short-Term Business Credit Institutions6153
Product category
Venture Lending / Specialty Finance
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Interest income from senior secured debt investments
TypeSubscription Recurring
Description

Primary revenue stream from interest income on a portfolio of senior secured venture growth loans. Q1 2026 total investment income reached $141.5 million, up 18.4% year-over-year, with $123.4M in total interest income. Portfolio is 98% floating-rate, providing yield upside as base rates rise. Effective portfolio yield was 12.8% in Q1 2026.

stockstory.org
2Equity investment returns and warrants
TypeLicensing Royalties
Description

Equity co-investments alongside debt positions, generating returns through capital gains, dividends, and warrant exercises. Variable component contributes to the supplemental dividend (e.g., $0.07 supplemental added to base $0.40 dividend in Q1 2026).

stocktitan.net
3Net Investment Income (NII)
TypeManaged Services
Description

Record NII of $88.1 million ($0.48 per share) in Q1 2026, representing a 14% year-over-year increase. NII covered the dividend at 120%, demonstrating strong earnings support with $149.1M in spillover income available.

in.investing.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Others, Technology or R&D
Pricing details2 tiers
1Custom venture debt financing — quote-based, not publicly disclosed
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing is not publicly listed; deal terms are customized per company based on stage, sector dynamics, and capital needs. The company website notes 'We create a custom financing solution for each of our partnerships.' Hercules operates as an internally managed BDC and does not publish standardized pricing.

htgc.com
2Sample deal: Lexicon Pharmaceuticals — $100M loan facility at prime + 3.1% with 9.85% floor, 18-month interest-only period
ModelUsage-basedBilling cadenceMulti-year contract
Notes

Floating-rate senior secured term loans. Example: Lexicon deal carried a floating interest rate of prime plus 3.1% with a 9.85% floor, 18-month interest-only period, full repayment due May 2030. Terms vary by borrower risk profile.

investing.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1Ventured Growth
Description

Hercules Capital's branded podcast featuring interviews with finance leaders and innovators.

htgc.com
Core offering1 text field

Hercules Capital provides non-dilutive senior secured venture debt and equity co-investments to venture-backed and growth-stage technology and life sciences companies. The company originates customized floating-rate loan facilities — typically priced at prime plus a spread with interest-only periods — alongside equity co-investments and milestone-based tranches, supporting use cases from clinical development and runway extension to acquisitions and IPO preparation.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • $1.81 billion record new debt and equity commitments in Q1 2026
+5 more records
Product overview1 text field

Hercules Capital operates as a single unified specialty finance platform — the largest business development company (BDC) focused on venture lending — structured around two core service verticals: Hercules Capital Technology Lending and Hercules Capital Life Sciences Lending. Together, these verticals form the company's non-dilutive growth capital offering for innovative, venture-backed entrepreneurs and their VC partners across technology and life sciences sectors. Beyond its core lending business, Hercules Capital also operates the Ventured Growth Podcast as a thought leadership and brand-building platform, featuring CFO and founder conversations that reinforce its position in the innovation economy. Since inception in December 2003, Hercules has committed over $27 billion to more than 700 companies, with a dedicated Technology Group (led by Steve Kuo) and Life Sciences Group (led by R. Bryan Jadot) operating as integrated sub-platforms within the larger BDC.

Product and service1 record
1Hercules Capital Technology Lending
Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCore Service ProviderTypeImplementation/ SI/ Consulting PartnerAnnounced on2026-06-18
Description

PricewaterhouseCoopers LLP is Hercules Capital's independent auditor, with ratification of PwC as auditor for 2026 on the agenda of the June 18, 2026 Annual Meeting of Stockholders. Proxy statement was filed on April 23, 2026.

Strategic tierFeatured Portfolio Company / Co-PromotionTypeStrategic or Co-development PartnerAnnounced on2026-05-26
Description

Featured portfolio company; Hercules Capital featured Fin's CFO Dan Griggs on the Ventured Growth podcast discussing Fin's $250 million in debt financing from Hercules and the AI-native customer service transformation. Intercom rebranded to Fin on May 12, 2026.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Largest publicly traded BDC (NASDAQ: ARCC) managed by Ares Management. Operates a much broader middle-market direct lending strategy rather than specializing in venture-backed tech and life sciences, but is the dominant incumbent in the BDC category.

TypeBroad incumbent
Description

Large alternative credit manager with a venture lending unit that competes for direct lending deals. Broader middle-market focus but with venture debt capabilities that overlap with Hercules.

TypeBroad incumbent
Description

Diversified financial services firm with a venture lending group (acquired from PacWest) that competes for tech venture debt deals. Several Hercules MDs (e.g., Ruslan Sergeyev) came from Stifel's venture lending team.

TypeBroad incumbent
Description

Large alternative asset manager with venture lending capabilities including direct lending to growth-stage companies. Competes indirectly through its private credit funds, including co-investment alongside Hercules in deals like Perk.

TypeDirect peer
Description

Publicly traded business development company (NASDAQ: TRIN) providing venture debt and equipment financing to growth-stage technology and life sciences companies. Highly comparable business model, including sponsor finance and life sciences verticals.

TypeDirect peer
Description

Direct venture debt competitor focused on technology and life sciences growth-stage companies with senior secured loans and warrants. Closest comparable in terms of vertical focus, ticket size, and equity co-investment model.

TypeDirect peer
Description

Specialty finance company (Apollo-managed) providing senior secured loans to growth and middle-market companies across healthcare, technology, and life sciences. Competes head-to-head with Hercules in life sciences venture lending.

TypeDirect peer
Description

Publicly traded specialty finance company (NASDAQ: RWAY) providing senior secured loans to venture and non-venture growth-stage companies, with overlap in tech and life sciences verticals.

TypeDirect peer
Description

Specialty finance firm (now part of Axos Financial) that provides senior secured loans to life sciences and healthcare companies. Several Hercules executives, including Adam Soller, came from Oxford, highlighting direct competitive overlap.

TypeDirect peer
Description

BDC (NASDAQ: HRZN) that provides secured loans to development-stage and venture-backed technology, life sciences, healthcare, and sustainability companies. Closely mirrors Hercules' venture lending strategy and loan structure.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers19 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds8 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors14 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment354 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Hercules Capital

Venture Lending / Specialty Financehtgc.com

Hercules Capital firmographics

Firmographics
Name
Hercules Capital
Legal name
Hercules Capital, Inc.
Website
https://htgc.com
Company type
Public
Founded year
2003
Operating status
Operating
Headcount range
101–250 employees
Ownership category
akta.pro rank

Hercules Capital industry classification

Industry
Product category
Venture Lending / Specialty Finance
NAICS
Funds, Trusts, and Other Financial Vehicles (525), Commercial Banking (522110)
SIC
Short-Term Business Credit Institutions (6153)
akta.pro industry
PRIMARYFSANAIAI
Venture Debt with Warrants (Hybrid Debt-Equity)
SECONDARYFSANAIAB
Independent Venture Debt Funds / Platforms
SECONDARYFSANAIAG
Venture Growth / Recurring Revenue Credit Funds

Keywords

  • Venture debt financing
  • Senior secured loans
  • Business development company
  • Growth capital lending
  • Non-dilutive financing

Where Hercules Capital is headquartered

Location

Headquarters

HQ city
San Mateo
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Hercules Capital business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Others, Technology or R&D

Revenue model

  1. Interest income from senior secured debt investments: Primary revenue stream from interest income on a portfolio of senior secured venture growth loans. Q1 2026 total investment income reached $141.5 million, up 18.4% year-over-year, with $123.4M in total interest income. Portfolio is 98% floating-rate, providing yield upside as base rates rise. Effective portfolio yield was 12.8% in Q1 2026.
  2. Equity investment returns and warrants: Equity co-investments alongside debt positions, generating returns through capital gains, dividends, and warrant exercises. Variable component contributes to the supplemental dividend (e.g., $0.07 supplemental added to base $0.40 dividend in Q1 2026).
  3. Net Investment Income (NII): Record NII of $88.1 million ($0.48 per share) in Q1 2026, representing a 14% year-over-year increase. NII covered the dividend at 120%, demonstrating strong earnings support with $149.1M in spillover income available.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom venture debt financing — quote-based, not publicly disclosed
Usage-basedMulti-year contractSample deal: Lexicon Pharmaceuticals — $100M loan facility at prime + 3.1% with 9.85% floor, 18-month interest-only period

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

Hercules Capital product offering

Product offering

Core offering

Hercules Capital provides non-dilutive senior secured venture debt and equity co-investments to venture-backed and growth-stage technology and life sciences companies. The company originates customized floating-rate loan facilities — typically priced at prime plus a spread with interest-only periods — alongside equity co-investments and milestone-based tranches, supporting use cases from clinical development and runway extension to acquisitions and IPO preparation.

Product overview

Hercules Capital operates as a single unified specialty finance platform — the largest business development company (BDC) focused on venture lending — structured around two core service verticals: Hercules Capital Technology Lending and Hercules Capital Life Sciences Lending. Together, these verticals form the company's non-dilutive growth capital offering for innovative, venture-backed entrepreneurs and their VC partners across technology and life sciences sectors. Beyond its core lending business, Hercules Capital also operates the Ventured Growth Podcast as a thought leadership and brand-building platform, featuring CFO and founder conversations that reinforce its position in the innovation economy. Since inception in December 2003, Hercules has committed over $27 billion to more than 700 companies, with a dedicated Technology Group (led by Steve Kuo) and Life Sciences Group (led by R. Bryan Jadot) operating as integrated sub-platforms within the larger BDC.

Differentiator

Problem solved

Functional benefit

Brands

  • Ventured Growth: Hercules Capital's branded podcast featuring interviews with finance leaders and innovators.

Products and services

  • Hercules Capital Technology Lending

Quantifiable outcome

  • $1.81 billion record new debt and equity commitments in Q1 2026
  • +5 more outcomes

Companies that use Hercules Capital

Customer profile

Named customers19 records

Segments5 records

Ideal customer profiles3 records

Hercules Capital technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Hercules Capital partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core service provider and featured portfolio company / co-promotion.

  • PricewaterhouseCoopers LLPcore service providerImplementation/ SI/ Consulting Partner · 18 June 2026PricewaterhouseCoopers LLP is Hercules Capital's independent auditor, with ratification of PwC as auditor for 2026 on the agenda of the June 18, 2026 Annual Meeting of Stockholders. Proxy statement was filed on April 23, 2026.
  • Fin (Intercom)featured portfolio company / co-promotionStrategic or Co-development Partner · 26 May 2026Featured portfolio company; Hercules Capital featured Fin's CFO Dan Griggs on the Ventured Growth podcast discussing Fin's $250 million in debt financing from Hercules and the AI-native customer service transformation. Intercom rebranded to Fin on May 12, 2026.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Hercules Capital competitors and assessment

Company assessment

Broad incumbents

  • Ares Capital: Largest publicly traded BDC (NASDAQ: ARCC) managed by Ares Management. Operates a much broader middle-market direct lending strategy rather than specializing in venture-backed tech and life sciences, but is the dominant incumbent in the BDC category.
  • Golub Capital: Large alternative credit manager with a venture lending unit that competes for direct lending deals. Broader middle-market focus but with venture debt capabilities that overlap with Hercules.
  • Stifel Financial: Diversified financial services firm with a venture lending group (acquired from PacWest) that competes for tech venture debt deals. Several Hercules MDs (e.g., Ruslan Sergeyev) came from Stifel's venture lending team.
  • Blue Owl Capital: Large alternative asset manager with venture lending capabilities including direct lending to growth-stage companies. Competes indirectly through its private credit funds, including co-investment alongside Hercules in deals like Perk.

Direct peers

  • Trinity Capital: Publicly traded business development company (NASDAQ: TRIN) providing venture debt and equipment financing to growth-stage technology and life sciences companies. Highly comparable business model, including sponsor finance and life sciences verticals.
  • TriplePoint Capital: Direct venture debt competitor focused on technology and life sciences growth-stage companies with senior secured loans and warrants. Closest comparable in terms of vertical focus, ticket size, and equity co-investment model.
  • MidCap Financial: Specialty finance company (Apollo-managed) providing senior secured loans to growth and middle-market companies across healthcare, technology, and life sciences. Competes head-to-head with Hercules in life sciences venture lending.
  • Runway Growth Finance: Publicly traded specialty finance company (NASDAQ: RWAY) providing senior secured loans to venture and non-venture growth-stage companies, with overlap in tech and life sciences verticals.
  • Oxford Finance: Specialty finance firm (now part of Axos Financial) that provides senior secured loans to life sciences and healthcare companies. Several Hercules executives, including Adam Soller, came from Oxford, highlighting direct competitive overlap.
  • Horizon Technology Finance: BDC (NASDAQ: HRZN) that provides secured loans to development-stage and venture-backed technology, life sciences, healthcare, and sustainability companies. Closely mirrors Hercules' venture lending strategy and loan structure.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Hercules Capital social profiles

Digital presence

Hercules Capital compliance and trust

Trust signal

Compliance2 records

Hercules Capital financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Hercules Capital leadership team

Management profile

Number of profiles

Profiles11 records

Hercules Capital subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Hercules Capital funding detail

Funding detail

Funding overview

Funding rounds8 records

Investors14 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Hercules Capital M&A and investment

M&A and investment

M&A1 record

Investments354 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hercules Capital

What does Hercules Capital do?

Hercules Capital provides non-dilutive senior secured venture debt and equity co-investments to venture-backed and growth-stage technology and life sciences companies. The company originates customized floating-rate loan facilities — typically priced at prime plus a spread with interest-only periods — alongside equity co-investments and milestone-based tranches, supporting use cases from clinical development and runway extension to acquisitions and IPO preparation.

Is Hercules Capital a public or private company?

Hercules Capital is a public company. It is classified as public and is currently operating.

When was Hercules Capital founded?

Hercules Capital was founded in 2003. It employs 101 to 250 people.

Where is Hercules Capital based?

Hercules Capital is headquartered in San Mateo, United States, in the North America region.

How does Hercules Capital make money?

Three revenue lines are on record. Interest income from senior secured debt investments are the primary driver. The others are equity investment returns and warrants and net Investment Income (NII).

Who are Hercules Capital's main competitors?

Broad incumbents on record are Ares Capital, Golub Capital, Stifel Financial and Blue Owl Capital. Direct peers are Trinity Capital, TriplePoint Capital, MidCap Financial, Runway Growth Finance, Oxford Finance and Horizon Technology Finance.

Does Hercules Capital have an API?

No public API is recorded for Hercules Capital.

What industry is Hercules Capital in?

Hercules Capital's product category is Venture Lending / Specialty Finance. Its primary akta.pro industry code is FSANAIAI, Venture Debt with Warrants (Hybrid Debt-Equity), with a secondary code of FSANAIAB, Independent Venture Debt Funds / Platforms. Its NAICS code is 525 and its SIC code is 6153.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Startup ResearcherHercules Capital Tops $4 Billion in Annual CommitmentsHercules Capital surpassed $4 billion in annual debt and equity commitments for the first time, exceeding its previous record of $3.92 billion. The company has committed $29 billion to over 700 companies since its 2003 inception, focusing on venture and growth stage lending.Yahoo$250,000 in Golub Capital and Hercules Capital: Why BDC Income Belongs in a Roth IRAA $250,000 portfolio split between Golub Capital and Hercules Capital BDCs yields about $25,760 annually in ordinary distributions. In a taxable account, roughly $6,182 goes to taxes, while a Roth IRA keeps all of it. Reinvesting the savings at 4% grows the Roth advantage to about $184,000 after 20 years.247wallst$250,000 in Golub Capital and Hercules Capital: Why BDC Income Belongs in a Roth IRAHolding $250,000 in Golub Capital and Hercules Capital in a Roth IRA saves about $6,182 annually in taxes at the 24% bracket. The advantage grows with higher brackets, and reinvesting the savings at 4% yields about $184,000 after 20 years. The article advises testing Roth conversions against this recurring gap.Seeking AlphaHercules Capital: Accumulation Opportunity At 15% Below Historical P/NAVHercules Capital posted robust portfolio and net investment income growth in Q3, driven by new originations. Its portfolio is 97.9% variable-rate, positioning it for further net investment income upside. The stock trades at a premium, but its P/NAV is about 15% below its 3-year average, offering an entry point for income-focused investors.Business & FinancialAtea Pharmaceuticals Secures Credit Facility For Up To $200 Million From Hercules CapitalAtea Pharmaceuticals secured a credit facility from Hercules Capital for up to $200 million, receiving $65 million at closing. The company expects topline results from its second Phase 3 trial, C-FORWARD, in early 2027 and an NDA submission in mid-2027. The financing aims to support its goal of a US launch of BEM/RZR in 2028.Simply Wall St3 US Credit Stocks Retail Investors Are Watching As Rate Pressure Stays HigherGCM Grosvenor, Capital Southwest, and Hercules Capital are highlighted as floating-rate, short-maturity credit stocks. GCM Grosvenor generates $567M in asset management revenue, Capital Southwest $247M in investment income, and Hercules Capital $568M in revenue. The article notes funding cost pressures may affect their earnings visibility.Simply Wall StLearn Why The Bull Case For Hercules Capital Stock Could Change Following Q3 Earnings GuidanceHercules Capital reported Q3 2026 revenue of $140.12 million and net income of $93.57 million, affirming a $0.40 per share cash distribution with a $0.07 supplemental payout. It issued Q4 guidance linking higher prepayments to stronger total and net investment income. The guidance's success depends on actual prepayment activity, which could affect earnings quality and distribution sustainability.MarketBeatHercules Capital Q3 Earnings Call HighlightsHercules Capital reported Q3 2026 results with record year-to-date originations of $3.44 billion and $140.1 million in total investment income. Net investment income covered the base distribution by 118%, and management expects higher income in Q4 as prepayments normalize. The company expects 2026 to exceed 2025 records for commitments and fundings.MarketBeatHercules Capital Q3 Earnings Call HighlightsHercules Capital reported Q3 2026 results with record year-to-date originations of $3.44 billion and net investment income of $87.3 million. Management expects higher investment income in Q4 as prepayments normalize, with core yield guided at 11.8%-12%.YahooHercules Capital Inc (HTGC) (Q3 2026) Earnings Call Highlights: Record Year-to-Date ...Hercules Capital reported Q3 2026 net investment income of $87.3 million, down from $94.3 million in Q2, with total investment income of $140.1 million. Year-to-date income reached record $268.4 million, and Q4 core yield guidance is 11.8%-12%. CEO Scott Bluestein expects core yields to stabilize in that range.